Attached files
| file | filename |
|---|---|
| 10-K - OCCULOGIX 10-K 12-31-2009 - TearLab Corp | form10k.htm |
| EX-31.2 - EXHIBIT 31.2 - TearLab Corp | ex31_2.htm |
| EX-14.1 - EXHIBIT 14.1 - TearLab Corp | ex14_1.htm |
| EX-32.2 - EXHIBIT 32.2 - TearLab Corp | ex32_2.htm |
| EX-23.1 - EXHIBIT 23.1 - TearLab Corp | ex23_1.htm |
| EX-32.1 - EXHIBIT 32.1 - TearLab Corp | ex32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - TearLab Corp | ex31_1.htm |
| EX-21.1 - EXHIBIT 21.1 - TearLab Corp | ex21_1.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
(a)
|
the Registration Statement (Form S-3/A Amendment No. 3 No. 333-141098) and related prospectus of OccuLogix, Inc. for the registration of 9,441,749 shares of common stock;
|
|
(b)
|
the Registration Statement (Form S-3 No. 333-157269) and related prospectus of OccuLogix, Inc.;
|
|
(c)
|
the Registration Statement (Form S-8 No. 333-124505) pertaining to the Employees’ Stock Option Plan of OccuLogix, Inc.; and
|
|
(d)
|
the Registration Statement (Form S-8 No. 333-155163) pertaining to Options Granted Under the OcuSense, Inc. 2003 Stock Option/Stock Issuance Plan and Assumed by OccuLogix, Inc., and Options Granted Under a Certain Option Agreement between OccuLogix, Inc. and Stephen Parks.
|
of our report dated March 14, 2008, except for Note 2, as to which the date is March 26, 2010, with respect to the consolidated financial statements and financial statement schedule, as they relate to the year ended December 31, 2007, of OccuLogix, Inc., included in this Annual Report for the year ended December 31, 2009.
|
March 26, 2010
|
/s/ Ernst & Young LLP
|
|
Toronto, Canada
|
Chartered Accountants
|
|
Licensed Public Accountants
|